[運動病: 問題 の 現在の 見方. 文献レビュー]
N L Kunelskaya1,2, E V Baibakova1, Z O Zaoeva1
1Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Moscow, Russia.
Vestnik otorinolaringologii
|September 3, 2025
まとめ
運動病は 複雑な生理学的状態で 何年も研究されてきました この レビュー に は 歴史 的 な 理論 や 現代 の 理論,診断 基準,運動 病 の 効果的な 治療 方法 が 含ま れ て い ます.
科学分野:
- 神経科学
- 生理学
- 臨床医学
背景:
- 運動不良は複雑な基礎的メカニズムを持つ一般的な状態です.
- その病原性を理解することは 効果的な介入の開発に不可欠です
研究 の 目的:
- 移動病の総合的な概要を提供するためです.
- その起源に関する 歴史的,現代的な理論を議論する.
- 最新の臨床診断基準と管理戦略を提示する
主な方法:
- 移動病に関する過去と現在の研究の文献レビュー.
- 病因と病原性に関する理論の分析
- 治療と予防の方法を検討する.
主要な成果:
- 運動病の説明には 複数の理論があり 時間の経過とともに進化しています
- バラニ協会は2021年に新しい臨床診断基準を確立しました.
- 薬物療法と行動療法の両方が有効です
結論:
- 運動病の理解は大きく進歩しました
- 現在の診断基準は 一貫した患者評価に役立ちます
- 移動 病 の 治療 に は,治療 方法 の 組み合わせ が 最善 です.
関連する概念動画
Equilibrium and Balance
5.1K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
5.1K
Pathophysiology of Vomiting
1.1K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
1.1K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
439
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
439
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
593
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
593
Cholinergic Antagonists: Therapeutic Uses
868
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
868


